Azione PLPL PLANDAÍ BIOTECHNOLOGY, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Plandaí Biotechnology, Inc.

Azioni

PLPL

US72703D1000

Mercato chiuso - OTC Markets
Altri mercati azionari
 20:44:46 16/07/2024 		Variaz. 5gg Var. 1 gen.
0,0002 USD 0,00% Grafico intraday di Plandaí Biotechnology, Inc. 0,00% 0,00%
2023 Plandaí Biotechnology, Inc. ha annullato l'acquisizione di ByoPlanet International, LLC. CI
2023 Rick O'Shea assume il ruolo di CEO di Plandaí Biotechnology, Inc. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.
CapitalGainsReport: Penny Stock Breakout Watchlist (EPAZ, DPLS, PLPL, BDPT)
Sub-Penny Spotlight (HBRM, PLPL, CNNA, AITX)
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
CapitalGainsReport: News Catalysts Could Send These Stocks Soaring (EPAZ, GGSM, KYNC, PLPL)
Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc
Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC.
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
EV Hotel Corp. terminated the acquisition of Plandaí Biotechnology, Inc. in a reverse merger transaction.
EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. in a reverse merger transaction.
Plandaí Biotechnology : Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
Plandaí Biotechnology : SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
Plandaí Biotechnology : Plandai Biotechnology, Inc. Reinstated
Plandai Biotechnology Provides Comment on SEC Action
Plandaí Biotechnology Announces Successful Completion of Government Inspection of Affiliate Protext Pharma’s Proposed Medical Cannabis Facility
Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market
Plandaí Biotechnology to Focus on International Nutraceutical Cannabis Opportunities
Plandai Biotechnology Discusses Cannabis Extract Opportunities and Research Potential
Plandai Biotechnology Discusses Potential for Using Phytofare in Treating Type II Diabetes
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione PLPL
  4. Notizie Plandaí Biotechnology, Inc.
  5. Altre lingue